Komori
Shibuya (6340) · RiskFirst stated

Risk from revisions and changes to medical-equipment manufacturing standards in each country

First written in FY2018. . Latest entry: FY2018.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Disruption to Manufacturing and Sales Due to Changes in National Safety and Environmental StandardsA theme 43 companies write about · 45 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2022: 4 of 17 companies on the "Worse" side.

2 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 43 companies compared. The sentences above are computed from all 43.
Full recordFilings, disclosures and news, newest first
  1. FY2018First statedAnnual report

    「The Group manufactures and sells medical equipment, including hemodialysis systems and laser treatment equipment, with regulatory approval in accordance with standards established by each country. If these standards are revised or changed, the measures required to address such changes could adversely affect business performance.」

    States that responding to revisions or changes in standards in each country for hemodialysis systems and laser treatment equipment could affect business performance.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shibuya's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.